← Eichor
Condition: Acinetobacter Pneumonia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Acinetobacter Pneumonia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Phase 4 · 3 location(s) · Rambam Health Care Campus · NCT05922124A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacte
Phase N/A · 12 location(s) · Innoviva Specialty Therapeutics · NCT06746883A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex
Phase 2 · 6 location(s) · Omnix Medical Ltd · NCT06087536Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients W
Phase 3 · 1 location(s) · BioVersys SAS · NCT07326540Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort Study
Phase N/A · 1 location(s) · Sichuan Provincial People's Hospital · NCT07601711A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infecti
Phase 1 · 4 location(s) · Innoviva Specialty Therapeutics · NCT06801223
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.